204 Participants Needed

Present Centered Psychotherapy for PTSD

(MERA Trial)

Recruiting at 1 trial location
BC
SR
DC
Overseen ByDeveney Ching, MA
Age: 18 - 65
Sex: Any
Trial Phase: Academic
Sponsor: VA Office of Research and Development
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores ways to help Veterans with PTSD (post-traumatic stress disorder) manage their emotions and reduce impulsive aggression, a common issue. It compares a new emotion regulation treatment, called Manage Emotions to Reduce Aggression (MERA), with a control group to determine if it better prepares Veterans for PTSD treatment. Veterans who have experienced combat since 9/11, have PTSD symptoms, and struggle with impulsive aggressive acts like yelling or hitting, might be a good fit for this study. The goal is to help Veterans improve their emotional coping skills and ultimately recover from PTSD. As an unphased trial, this study offers Veterans the opportunity to contribute to innovative research that could enhance PTSD treatment strategies.

Will I have to stop taking my current medications?

You won't have to stop taking your current medications, but you must agree not to change any psychotropic medications (medications that affect your mind, emotions, and behavior) during the study.

Is there any evidence suggesting that this trial's treatments are likely to be safe?

Research shows that Present Centered Psychotherapy (PCT) is generally safe and well-tolerated for treating PTSD. Studies have found that patients often continue with PCT treatment, possibly more than with some other therapies, suggesting it is manageable for most people.

Manage Emotions to Reduce Aggression (MERA) focuses on teaching skills to control emotions and reduce aggression. While specific safety data for MERA is unavailable, its emphasis on emotional management suggests it is likely low-risk. Both treatments aim to help Veterans better manage their emotions, potentially improving well-being.12345

Why are researchers excited about this trial?

Researchers are excited about Present Centered Psychotherapy (PCT) and Manage Emotions to Reduce Aggression (MERA) for PTSD because these approaches focus on managing emotions and reducing aggression through concise therapy sessions. Unlike traditional PTSD treatments that often require long-term commitment, both PCT and MERA involve just three individual 90-minute sessions over three weeks, making them more accessible and time-efficient. Additionally, these therapies do not rely on medication, which can have side effects, but instead focus on improving emotional regulation and personal coping strategies. This could offer a promising alternative for individuals seeking effective, short-term treatment without the complications of pharmacotherapy.

What evidence suggests that this trial's treatments could be effective for PTSD?

Research has shown that the Manage Emotions to Reduce Aggression (MERA) program, one of the treatments in this trial, can help Veterans with PTSD by reducing aggression and improving emotional management. In a small initial study, Veterans who participated in MERA demonstrated a noticeable decrease in aggressive behavior and better emotional control, with a moderate impact measured by Cohen's d = -0.55.

Studies also indicate that Present Centered Psychotherapy (PCT), another treatment option in this trial, effectively reduces the severity of PTSD symptoms. PCT works well for Veterans and is often as effective as other trauma-focused therapies. Overall, both treatments in this trial have strong evidence supporting their ability to help manage PTSD symptoms.12567

Who Is on the Research Team?

SR

Shannon R. Miles, PhD

Principal Investigator

James A. Haley Veterans' Hospital, Tampa, FL

Are You a Good Fit for This Trial?

This trial is for Veterans who served since 9/11, have PTSD or subthreshold PTSD, and show impulsive aggression. They must not change their psychotropic medications during the study and need an independent observer to verify aggressive acts.

Inclusion Criteria

I agree not to change my mental health medications during the study.
I am a veteran who served in a combat zone after 9/11.
I have someone over 18 who can report on my aggressive behaviors.
See 5 more

Exclusion Criteria

Currently suicidal with intent of self-harm in the last week
Currently homicidal with plans to hurt a specific person
I have been diagnosed with bipolar disorder or a psychotic disorder.
See 2 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive 3 individual 90-minute sessions of either MERA or PCT over 3 weeks

3 weeks
3 visits (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment

8 weeks
1 visit (in-person)

Long-term follow-up

Assessment of Evidence Based Psychotherapy (EBP) initiation at 6 months posttreatment

6 months

What Are the Treatments Tested in This Trial?

Interventions

  • Manage Emotions to Reduce Aggression
  • Present Centered Psychotherapy
Trial Overview The MERA trial compares a new 3-session emotion regulation treatment with a control group to see if it can reduce impulsive aggression in Veterans and prepare them for PTSD treatment.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: Manage Emotions to Reduce Aggression (MERA)Experimental Treatment1 Intervention
Group II: Present Centered Psychotherapy (PCT)Active Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

VA Office of Research and Development

Lead Sponsor

Trials
1,691
Recruited
3,759,000+

VA Boston Healthcare System

Collaborator

Trials
73
Recruited
971,000+

University of Houston

Collaborator

Trials
155
Recruited
48,600+

Texas A&M University

Collaborator

Trials
156
Recruited
28,900+

University of South Florida

Collaborator

Trials
433
Recruited
198,000+

Michael E. DeBakey VA Medical Center

Collaborator

Trials
68
Recruited
17,200+

Published Research Related to This Trial

In a study of 45 veterans with PTSD related to military sexual trauma, those who underwent cognitive processing therapy showed significantly lower negative cognition scores after treatment compared to those who received present centered therapy.
Negative cognitions were found to be positively correlated with the severity of PTSD, highlighting the importance of addressing these thoughts in treatment for better outcomes.
Effects of cognitive processing therapy on PTSD-related negative cognitions in veterans with military sexual trauma.Holliday, R., Link-Malcolm, J., Morris, EE., et al.[2022]
In a study of 70 adult survivors of interpersonal violence undergoing Cognitive Processing Therapy (CPT) for PTSD, factors such as reduced patient fear and avoidance were strong predictors of better treatment outcomes, highlighting the importance of patient engagement in therapy.
Therapist behaviors also played a crucial role, with the use of Socratic dialogue significantly increasing the likelihood of treatment completion, while encouraging patient affect was linked to lower completion rates.
Leveraging observational data to identify in-session patient and therapist predictors of cognitive processing therapy response and completion.Alpert, E., Carpenter, JK., Smith, BN., et al.[2023]
In a pilot study involving 31 male military veterans with PTSD and severe anger issues, the TARGET therapy showed a significantly lower dropout rate (29%) compared to prolonged exposure therapy (64%), indicating better retention and potential acceptability of TARGET.
Both TARGET and prolonged exposure therapy led to improvements in emotion regulation, hope, and reductions in PTSD symptoms and mental health problems, suggesting that TARGET may be an effective treatment option for this population.
Randomized clinical trial pilot study of prolonged exposure versus present centred affect regulation therapy for PTSD and anger problems with male military combat veterans.Ford, JD., Grasso, DJ., Greene, CA., et al.[2019]

Citations

Manage Emotions to Reduce Aggression (MERA)About 50% of Veterans with full and subthreshold posttraumatic stress disorder (PTSD) reported engaging in aggression after returning from deployment. This ...
2.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/32947454/
Manage Emotions to Reduce Aggression: A Pilot Study of ...Veterans in the intent-to-treat sample demonstrated a significant decrease in their frequency of aggression (Cohen's d = -0.55) and emotion dysregulation ( ...
Using Emotion Regulation to Decrease Aggression in ...The investigators for this study believe that equipping Veterans with emotion regulation skills and knowledge about PTSD treatments may help them initiate, ...
Changes in anger and aggression after treatment for PTSD ...PTSD treatments reduced anger and aggression with effects similar to anger and aggression treatments; innovative psychotherapies are needed.
A Pilot Study of a Brief Treatment to Help Veterans Reduce ...Veterans in the intent-to-treat sample demonstrated a significant decrease in their frequency of aggression (Cohen's d = -0.55) and emotion dysregulation ( ...
Emotion dysregulation as an underlying mechanism of ...Emotion dysregulation mediates relationship between impulsive aggression and PTSD. Teaching veterans with PTSD emotion regulation skills may reduce aggression.
Changes in anger and aggression after treatment for PTSD in ...Objective: To examine whether treating posttraumatic stress disorder (PTSD) reduces anger and aggression and if changes in PTSD symptoms are associated with ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security